Therapeutic applications of octreotide in pediatric patients

Saudi Journal of Gastroenterology

Volumn 18, Issue 2, 2012, Pages 87-94

  Al Hussaini, Abdulrahman ^a   Butzner, Decker ^b  

^a KING FAHAD MEDICAL CITY   (Saudi Arabia)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Chronic diarrhea; dumping syndrome; gastrointestinal bleeding; octreotide; pancreas

Indexed keywords

ANTIBIOTIC AGENT; OCTREOTIDE; PROPRANOLOL;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADOLESCENT; ARTICLE; ASCITES; BLOOD TRANSFUSION; BRADYCARDIA; CHILD; CHRONIC DIARRHEA; CHYLOTHORAX; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DATA BASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; FECES ANALYSIS; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GROWTH HORMONE DEFICIENCY; HEART VENTRICLE FIBRILLATION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; INFANT; MALE; MECKEL DIVERTICULUM; MEDICAL RECORD REVIEW; PANCREAS PSEUDOCYST; PEDIATRICS; PHARMACY; PORTAL HYPERTENSION; POSTGASTRECTOMY SYNDROME; PRESCHOOL CHILD; PSEUDOMONAS INFECTION; QT PROLONGATION; RESUSCITATION; SCHOOL CHILD; TYPHLITIS;

ADOLESCENT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; DIARRHEA; DUMPING SYNDROME; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; INFANT; MALE; OCTREOTIDE; RETROSPECTIVE STUDIES;

EID: 84858988477     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.93807     Document Type: Article

References (70)

1. Gyr KE, Meier R. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract. Digestion 1993;54(Suppl 1):14-9. (Pubitemid 23202555)
2. Lucey MR, Yamada T. Biochemistry and physiology of gastrointestinal somatostatin. Dig Dis Sci 1989;34(3 Suppl):5S-13S. (Pubitemid 19086726)
3. Whitehouse I, Beglinger C, Ruttimann G, Gyr K. Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue. Gut 1986;27:141-6. (Pubitemid 16124106)
4. Polak JM, Broom SR. Somatostatin localisation in tissues. Scand J Gastroenterol Suppl 1986;119:11-21.
5. Kraenzlin ME, Wood SM, Neufeld M, Adrian TE, Bloom SR. Effect of long acting somatostatin-analogue, SMS 201-995, on gut hormone secretion in normal subjects. Experientia 1985;41:738-40. (Pubitemid 15009268)
6. Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987;36:108-24. (Pubitemid 17028583)
7. Tauber MT, Harris AG, Rochiccioli P. Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr 1994;153:304-10. (Pubitemid 24137443)
8. Heikenen JB, Pohl JF, Werlin SJ, Bucuvalas JC. Octreotide in pediatric patients. J Pediatr Gasroenterol Nutr 2002;35:600-9. (Pubitemid 35417728)
9. Eroglu Y, Emerick KM, Whitington PF, Alonso EM. Octreotide therapy for control of acute gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 2004;38:41-7. (Pubitemid 39274466)
10. Grosman I, Simon D. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am J Gastroenterol 1990;85:1061-71.
11. Mosdell KW, Visconti JA. Emerging indications for octreotide therapy, Part 1. Am J Hosp Pharm 1994;51:1184-92. (Pubitemid 24144931)
12. Hadengue A. Somatostatin or octreotide in acute variceal bleeding. Digestion 1999;60 (Suppl 2):31-41 (Pubitemid 29178659)
13. McCormick PA, Dick R, Siringo S. Octreotide reduces azygous blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1990;2:489-92.
14. Hwang SJ, Lin HC, Chang CF, Lee FY, Lu CW, Hsia HC, et al. A randomized controlled trial comparing octreotide and vasopressin in the control of acute oesophageal bleeding. J Hepatol 1992;16:320-5.
15. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-60.
16. Sung JJ, Chung SC, Yung MY, Lai CW, Lau JY, Lee YT, et al. Prospective randomised study of effect of octreotide in rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995;346:1666-9. (Pubitemid 26003324)
17. Sadowski DC. Use of octreotide in the acute management of bleeding oesophageal varices. Can J Gastroenterol 1997;11:339-43. (Pubitemid 27263194)
18. Siafakas C, Fox VL, Nurko S. Use of octreotide for the treatment of severe gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 1998;26:356-9. (Pubitemid 28120043)
19. Jenkins SA, Taylor BA, Nott DM, Ellenbogen S, Haggie J, Shields R. Management of massive gastrointestinal haemorrhage from multiple sites of peptic ulceration with somatostatin and octreotide- A report of five cases. Gut 1992;33:404-7.
20. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Eng J Med 1996;334:246-54. (Pubitemid 26030676)
21. Nikolopoulou VN, Thomopoulos KC, Katsakoulis EC, Vasilopoulos AG, Margaritis VG, Vagianos CE. The effect of octreotide as an adjunct treatment in active nonvariceal upper gastrointestinal bleeding. J Clin Gastroenterol 2004;38:243-7. (Pubitemid 38233332)
22. Christiansen J, Ottenjann R, Von Arx F. Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding. Gastroenterology 1989;97:568-74. (Pubitemid 19205128)
23. Lin HJ, Perng CL, Wang K, Lee CH, Lee SD. Octreotide for arrest of peptic ulcer haemorrhage - a prospective, randomized controlled trial. Hepatogastroenterology 1995;42:856-60. (Pubitemid 26026445)
24. Mulligan C, Howell C, Hatley R, Martindale R, Clark J. Conservative management of pediatric pancreatic pseudocyst using octreotide acetate. Am Surg 1995;61:206-9.
25. Bosman-Vermeeren JM, Veereman-Wauters G, Broos P, Eggermant E. Somatostatin in the treatment of pancreatic pseudocyst in a child. J Pediatr Gastroenterol Nutr 1996;23:422-5. (Pubitemid 26423774)
26. Tissieres P, Bugmann P, Rimensberger PC, Mentha G, Lencoultre C, Belli DC. Somatostatin in the treatment of pancreatic pseudocyst complicating acute pancreatitis in a child with liver transplantation. J Pediatr Gastroenterol Nutr 2000;31:445-7.
27. Rushforth JA, Beck JM, McMahon M, Puntis JW. Resolution of pancreatic ascites with octreotide. Arch Dis Child 1993;68:135-6. (Pubitemid 23039316)
28. Cavallini G, Frulloni L. Somatostatin and octreotide in acute pancreatitis: the never-ending story. Dig Liver Dis 2001;33:192-201. (Pubitemid 32294184)
29. Greenberg R, Haddad R, Kashtan H, Kaplan O. The effects of somatostatin and octreotide on experimental and human acute pancreatitis. J Lab Clin Med 2000;135:112-21. (Pubitemid 30105069)
30. Malfertheiner P, Mayer D, Buchler M, Dominquesz-Munoz JE, Schiefer B, Ditschuneit H. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995;36:450-4.
31. Usadel KH, Uberla KK, Leuschner U. Treatment of acute pancreatitis with somatostatin. Results of the multi-center double-blind trial (APTS-Study). Dig Dis Sci 1985;30:992.
32. D'Amico D, Favia G, Biasiato R, Casaccia M, Falcome F, Fersini M, et al. The use of somatostatin in acute pancreatitis: Results of a multi-center trial. Hepatogastroenterology 1990;37:92-8. (Pubitemid 20092216)
33. Choi TK, Mok F, Zhan WH, Fan ST, Lai ECS, Wong J. Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut 1989;30:223-7. (Pubitemid 19058876)
34. Gullo L, Priori P, Scarpignato C, Baldoni F, Mattioli G, Barbara L. Effect of somatostatin 14 on pure human pancreatic secretion. Dig Dis Sci 1987;32:1065-70. (Pubitemid 17152010)
35. Lam JC, Aters S, Tobias JD. Initial experience with octreotide in the pediatric population. Am J Ther 2001;8:409-15. (Pubitemid 33753136)
36. Paran H, Neufeld D, Mayo A, Shwartz I, Singer P, Kaplan O, et al. Preliminary report of a prospective study in the treatment of severe acute pancreatitis. J Am Coll Surg 1995;181:121-4.
37. Binder M, Uhl W, Friess H, Malfertheiner P, Bachler MW. Octreotide in the treatment of acute pancreatitis: results of a unicentric prospective trial with three different octreotide dosages. Digestion 1994;55 Suppl 1:20-3. (Pubitemid 24020274)
38. Conway DR, Djuricin G, Prinz RA. The effect of somatostatin analogue (SMS 201-995) on pancreatic blood flow. Surgery 1988;104:1024-30. (Pubitemid 19011982)
39. Klar E, Rattner DW, Compton C, Stanford G, Chernow B, Warshow AL. Adverse effect of therapeutic vasoconstrictors in experimental acute pancreatitis. Ann Surg 1991;214:168-74.
40. Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C. Etiology and management of pediatric chylothorax. J Pediatr 2000;136:653-58. (Pubitemid 30318397)
41. DeLedinghen V, Ripault MP, Silvain C, Beauchant M, Raffoux N, Bouquet S. Subcutaneous octreotide for the prevention of early variceal bleeding. Hepatology 1996; 23:938-39.
42. Cerfolio RJ, Allen MS, Deschamps C, Trastek VF, Pairolero PC. Postoperative chylothorax. J Thorac Cardiovasc Surg 1996;112:1361-6; discussion 1365-6.
43. Browse NL, Wilson NM, Russo F, al-Hassan H, Allen DR. Aetiology and treatment of chylous ascites. Br J Surg 1992;79:1145-50.
44. Rosti L, Bini RM, Chessa M, Butera G, Drago M, Carminati M. The effectiveness of octreotide in the treatment of post-operative chylothorax. Eur J Pediatr 2002;161:149-50. (Pubitemid 34169864)
45. Cheung Y, Leung MP, Yip M. Octreotide for treatment of post-operative chylothorax. J Pediatr 2001;139:157-9.
46. Goyal A, Smith NP, Jesudason EC, Kerr S, Losty PD. Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia. J Pediatr Surg 2003;38:E19-20.
47. Au M, Weber TR, Fleming RE. Successful use of somatostatin in a case of neonatal chylothorax. J Pediatr Surg 2003;38:1106-7. (Pubitemid 36828888)
48. Nakabayashi H, Sagara H, Usukura N, Yoshimitsu K, Imamura T, Seta T, et al. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes 1981;30:440-45. (Pubitemid 11022836)
49. Bhatia C, Pratap U, Slavik Z. Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum. Arch Dis Child 2001;85:234-5. (Pubitemid 32822385)
50. Ballinger AB, Farthing MJ. Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol 1998;10:699-702. (Pubitemid 28383118)
51. Ohlbaum P, Galperine RI, Demarquez JL, Vergnes P, Martin C. Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child. J Pediatr Gastroenterol Nutr 1987;6:466-70. (Pubitemid 17073445)
52. Lamireau T, Galpérine RI, Ohlbaum P, Demarquez JL, Vergnes P, Kurzenne Y, et al. Use of a long acting somatostatin analogue in controlling ileostomy diarrhoea in infants. Acta Pediatr Scand 1990;79:871-2. (Pubitemid 20326653)
53. Inamdar S, Slim MS, Bostwick H, Godine L. Treatment of duodenocutaneous fistula with somatostatin analogue in a child with dermatomyositis. J Pediatr Gastroenterol Nutr 1990;10:402-4. (Pubitemid 20108205)
54. Couper RTL, Berzen A, Berall G, Sherman PM. Clinical response to the long acting somatostatin analogue SMS 201-995 in a child with congenital microvillus atrophy. Gut 1989;30:1020-4. (Pubitemid 19187949)
55. Jaros W, Biller J, Greer S, O'dorisio T, Grand R. Successful treatment of idiopathic secretory diarrhea of infancy with the somatostatin analogue SMS 201-995. Gastroenterology 1988;94:189-93. (Pubitemid 18029778)
56. Helfer N, Wyss M, Friedli B, Sizonenko PC. Tumeur carcinoide bronchique associee a une secretion exageree de prolactine (PRL) et d'hormone de croissance (STH); traitement par la sandostatine et la bromocriptine. Schweiz Med Wochenschr 1990;120(Suppl 34):26.
57. Guarino A, Berni Canani R, Spagnuolo MI, Bisceglia M, Boccia MC, Rubino A. In vivo and in vitro efficacy of octreotide for treatment of enteric cryptosporidiosis. Dig Dis Sci 1998;43:436-41. (Pubitemid 28124625)
58. Smith SS, Shulman DI, O'Dorisio TM, McClenathan DT, Borger JA, Bercu BB, et al. Watery diarrhea, hypokalemia, achlorohydria syndrome in an infant: effect of the long-acting somatostatin analogue SMS 201- 995 on the disease and linear growth. J Pediatr Gastroenterol Nutr 1987;6:710-16.
59. Geer RJ, Richards WO, O'Dorisio TM, Woltering EO, Williams S, Rice D, et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 1990; 212:678-87.
60. Hopman WP, Wolberink RG, Lamers CB, Van Tongeren JH. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Ann Surg 1988;207:155-9. (Pubitemid 18063596)
61. Primrose JN, Johnston D. Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy. Br J Surg 1989;76:140-4. (Pubitemid 19057008)
62. Tulassay Z, Tulassay T, Gupta R, Cierny G. Long acting somatostatin analogue in dumping syndrome. Br J Surg 1989;76:1294-95. (Pubitemid 20026711)
63. Petersen JM, Saltzman M, Sherwin RS, Lange R, McCallum RW. Somatostatin inhibits gastric emptying of solids and liquids in man (Abstract) Dig Dis Sci 1984;29:A64.
64. Hasler WL, Soudah HC, Owyang C. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome. J Pharmacol Exp Ther 1996;277:1359-65. (Pubitemid 27167147)
65. Fatti LM, Scacchi M, Lavezzi E, Pecori Giraldi F, De Martin M, Toja P, et al. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Clin Endocrinol (Oxf). 2006;65:626-30. (Pubitemid 44583823)
66. Herrington AM, George KW, Moulds CC. Octreotide-induced bradycardia. Pharmacotherapy 1998;18:413-6. (Pubitemid 28145162)
67. Battershill PE, Clissold SP. Octreotide: A review of its pharmacokinetic properties and therapeutic potential in conditions associated with excessive peptide secretion. Drugs 1989;38:658-702. (Pubitemid 19285390)
68. DeClue TJ, Malone JI, Bercu BB. Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy. J Pediatr 1990;116:747-50. (Pubitemid 20162829)
69. Glaser B, Landau H, Smilovici A, Nesher R. Persistent hyperinsulinaemic hypoglycaemia of infancy: long-term treatment with the somatostatin analogue Sandostatin. Clin Endocrinol 1989;31:71-80. (Pubitemid 19178146)
70. Dowling RH, Hussaini SH, Murphy GM, Besser GM, Wass JA. Gallstones during octreotide therapy. Metabolism 1992;41(9 Suppl 2):22-33.